InnovaPrep LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

InnovaPrep LLC - overview

Established

2009

Location

-, MO, US

Primary Industry

Medical Devices & Equipment

About

InnovaPrep LLC specializes in advanced microbiological testing tools that enhance preanalytical workflows, offering innovative solutions for various industries including healthcare and environmental monitoring. InnovaPrep LLC, founded in 2009 and headquartered in the United States, focuses on providing sophisticated microbiological testing solutions. The company has completed 2 deals, with its most recent funding event being a Seed round in March 2020, where it raised USD 0. 5 mn from Accelerate Ventures.


David Alburty serves as the CEO, guiding the company's operations and growth strategy. InnovaPrep specializes in providing advanced microbiological testing tools designed to enhance preanalytical workflows. Their core product offerings include the FluidPrep™ Concentrating Pipette System and the AirPrep™ Cub Sampler, among others. The FluidPrep™ system utilizes a patented Wet Foam Elution™ process to rapidly concentrate microorganisms and particles from large volumes of liquid samples, ranging from 0.


5 mL to 5 liters, making it suitable for applications including environmental monitoring, wastewater characterization, and biopharma research. The AirPrep™ Cub Sampler, a portable and adaptable aerosol sampling device, efficiently captures airborne particles and integrates seamlessly with the broader AirPrep™ Sampler System. These products serve a diverse clientele, including research institutions, healthcare facilities, government agencies, and industries focused on food safety and environmental monitoring, with geographical markets spanning North America, Europe, and parts of Asia. InnovaPrep's revenue model is primarily based on direct sales of its specialized testing equipment and consumables to a wide array of clients, including laboratories, food and beverage manufacturers, and governmental organizations.


Transactions typically occur through one-time purchases or through structured agreements for ongoing supply, particularly in sectors requiring consistent monitoring, such as public health and environmental testing. Clients may engage in contracts that outline the purchase of FluidPrep™ Concentrating Pipette Systems along with necessary consumables to ensure optimal performance. Pricing specifics for these products reflect the technology's advanced capabilities, catering to both B2B sectors and direct consumers while maintaining a focus on delivering high-quality solutions for microbiological testing. InnovaPrep is focused on expanding its product line and market reach following its recent Seed funding of USD 0.


5 mn in March 2020. The company plans to introduce new products aimed at enhancing microbiological testing capabilities and is targeting expansion into additional regions of Europe and Asia by the end of 2023. The funding will be utilized to support research and development initiatives as well as to facilitate entry into new geographic markets.


Current Investors

Accelerate Ventures

Primary Industry

Medical Devices & Equipment

Sub Industries

Biotechnology, Medical Equipment Distributors, Medical Supplies

Website

www.innovaprep.com

Verticals

E-commerce, Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.